Financial News
All News about Revance Therapeutics, Inc. - Common Stock

Boeing, Pacific Biosciences of California And Other Big Stocks Moving Lower On Monday
January 08, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities


Botox And Similar Injections Have Associated Risks: Consumer Group Pushes for Stronger Warnings
December 12, 2023
Via Benzinga
Exposures
Product Safety

What 10 Analyst Ratings Have To Say About Revance Therapeutics
November 22, 2023
Via Benzinga

Revance Therapeutics: Q3 Earnings Insights
November 08, 2023
Via Benzinga

Revance Therapeutics's Earnings Outlook
November 07, 2023
Via Benzinga

The Latest Analyst Ratings for Revance Therapeutics
November 06, 2023
Via Benzinga



Analyst Ratings for Revance Therapeutics
October 11, 2023
Via Benzinga

The Latest Analyst Ratings for Revance Therapeutics
September 20, 2023
Via Benzinga



Revance Appoints Erica Jordan as Chief Commercial Officer, Aesthetics
November 08, 2023
Via Business Wire

Revance to Participate in Upcoming Investor Conferences
November 06, 2023
Via Business Wire




Via Benzinga



Dow Falls 150 Points; AutoZone Earnings Top Views
September 19, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities



Crude Oil Rises Over 1%; Revance Therapeutics Shares Plummet
September 19, 2023
Via Benzinga
Topics
Stocks


Markets Open Lower; US Housing Starts Fall In August
September 19, 2023
Via Benzinga
Topics
Stocks
Exposures
US Equities

Revance Provides Corporate Update at Investor Day
September 19, 2023
Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.